Valuation Divi's Laboratories Limited

Equities

Market Closed - NSE India S.E. Other stock markets 04:35:02 08/05/2026 pm IST			5-day change	1st Jan Change
6,710.50 ^INR	+0.12%		+3.20%	+4.97%

01/04	Avendus Spark Upgrades Divi's Laboratories to Reduce from Sell, Price Target is INR5,840	MT
12/02	Jefferies Adjusts Divi's Laboratories' Price Target to INR8,100 From INR8,000, Keeps at Buy	MT

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	9,61,740	11,68,606	7,49,511	9,14,619	15,33,201	17,81,427	-	-
Change	-	21.51%	-35.86%	22.03%	67.63%	16.19%	-	-
Enterprise Value (EV) ¹	9,40,228	11,40,454	7,07,412	8,74,849	14,96,091	17,47,594	17,44,734	17,35,266
Change	-	21.3%	-37.97%	23.67%	71.01%	16.81%	-0.16%	-0.54%
P/E ratio	48.5x	39.5x	41.1x	57.2x	70x	69.5x	57.7x	47.4x
PBR	10.4x	9.96x	5.87x	6.74x	10.3x	10.8x	9.59x	8.38x
PEG	-	0.8x	-1.1x	-4.7x	1.9x	4.1x	2.8x	2.2x
Capitalization / Revenue	13.8x	13x	9.65x	11.7x	16.4x	16.7x	14.4x	12.2x
EV / Revenue	13.5x	12.7x	9.11x	11.2x	16x	16.4x	14.1x	11.9x
EV / EBITDA	32.9x	29.4x	29.9x	39.7x	50.4x	49.9x	41x	33.3x
EV / EBIT	36.1x	31.9x	34.9x	47.9x	58.3x	57.3x	46.4x	37.2x
EV / FCF	90.7x	95.1x	35.6x	339x	696x	182x	139x	99x
FCF Yield	1.1%	1.05%	2.81%	0.29%	0.14%	0.55%	0.72%	1.01%
Dividend per Share ²	20	30	30	30	30	33.84	37.16	41.37
Rate of return	0.55%	0.68%	1.06%	0.87%	0.52%	0.5%	0.55%	0.62%
EPS ²	74.75	111.5	68.69	60.27	82.53	96.59	116.4	141.6
Distribution rate	26.8%	26.9%	43.7%	49.8%	36.4%	35%	31.9%	29.2%
Net sales ¹	69,694	89,598	77,675	78,450	93,600	1,06,459	1,23,623	1,45,638
EBITDA ¹	28,599	38,819	23,678	22,050	29,680	35,011	42,547	52,140
EBIT ¹	26,044	35,704	20,246	18,270	25,660	30,509	37,569	46,634
Net income ¹	19,843	29,604	18,234	16,000	21,910	25,581	30,918	37,617
Net Debt ¹	-21,512	-28,152	-42,098	-39,770	-37,110	-33,833	-36,693	-46,161
Reference price ²	3,622.80	4,402.05	2,823.35	3,445.30	5,775.45	6,710.50	6,710.50	6,710.50
Nbr of stocks (in thousands)	2,65,469	2,65,469	2,65,469	2,65,469	2,65,469	2,65,469	-	-
Announcement Date	29/05/21	23/05/22	20/05/23	25/05/24	17/05/25	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
DIVI'S LABORATORIES LIMITED	69.47x	16.42x	49.91x	0.5%	1.89TCr
ELI LILLY AND COMPANY	27.83x	10.14x	20.87x	0.72%	85TCr
JOHNSON & JOHNSON	23.65x	5.46x	14.84x	2.41%	53TCr
ABBVIE INC.	24.57x	6.11x	12.43x	3.41%	36TCr
ROCHE HOLDING AG	16.67x	4.18x	10.31x	3.18%	32TCr
ASTRAZENECA PLC	22.87x	4.76x	13.54x	1.83%	28TCr
NOVARTIS AG	20.12x	5.43x	13.2x	3.09%	28TCr
MERCK & CO., INC.	49.69x	4.64x	17.34x	2.99%	28TCr
NOVO NORDISK A/S	13.18x	4.82x	9.89x	3.84%	20TCr
AMGEN INC.	21.33x	5.83x	10.12x	3.04%	18TCr
Average	28.94x	6.78x	17.25x	2.5%	32.95TCr
Weighted average by Cap.	25.44x	6.52x	15.28x	2.33%